LC–MS

The scientific community is discussing efforts to scale liquid chromatography–mass spectrometry for organoid research. Organoids, lab-grown miniature tissue models, produce small sample volumes that make standardized LC–MS analysis difficult, and researchers are exploring workflows and automation to handle larger studies. Advances here could accelerate drug testing and disease modeling by allowing proteomic analysis across many organoid samples at once.